MindRhythm

MindRhythm is a San Francisco-based digital health company founded in 2019, targeting critical gaps in neurodiagnostics. Its core technology is the Cranial Accelogram, a disposable medical device that generates a unique biomarker for detecting LVO strokes and assessing concussion recovery. The company's mission is to reduce time-to-treatment for stroke and improve management of mild traumatic brain injury through objective, point-of-care data. Led by experienced medical device executives, MindRhythm is developing its platform for applications in prehospital triage, sports medicine, and critical care.

The Cranial Accelogram, a novel non-invasive disposable device that detects a physiological biomarker (Headpulse) for diagnosing Large Vessel Occlusion strokes and monitoring concussion recovery.

In prehospital stroke triage, competitors include clinical assessment scales (e.g., RACE, LAMS), mobile stroke units (very high cost), and other emerging device-based technologies. In concussion, competition is from subjective symptom inventories, computerized cognitive tests, and other developing physiological monitoring platforms (e.g., balance, eye-tracking).